Wednesday, March 05, 2025 | 10:27 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Nifty Pharma gains 2.5%, crosses 10K mark for the 1st time since Oct 2018

Aurobindo Pharma, Biocon, Cipla, and JB Chemicals & Pharmaceuticals hit their respective 52-week highs on the NSE on Tuesday.

The government is now trying to understand how long it will take before the drug’s production can start in India
Premium

Biocon hit a new high of Rs 396, up 3 per cent, gaining 12 per cent in the past two trading days after its partner Mylan received a favourable ruling from US Patent and Trademark Appeal Board (PTAB).

SI Reporter Mumbai
Shares of pharmaceutical companies continued their northward journey on Tuesday with Nifty Pharma index crossing 10,000 mark after a gap of 19 months as Aurobindo Pharma, Biocon, Cipla and JB Chemicals & Pharmaceuticals hit their respective 52-week highs on the National Stock Exchange (NSE).

Glenmark Pharmaceuticals, Cadila Healthcare, Sun Pharmaceutical Industries, Aurobindo Pharma and Lupin were up in the range of 2 per cent to 5 per cent today.

The Nifty Pharma index rallied 2.5 per cent during the day to hit a high of 10,047 points, its highest level since October 3, 2018. At 10:45 am, the pharma index

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in